Research!America unveils 2016 policy wish list

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

RESEARCH!AMERICA unveiled its policy wish list for 2016, urging Congress to take action on several research priorities.

“Congress should act this year to sustain robust funding for federal health agencies, advance medical innovation and mental health legislation, and permanently repeal the medical device tax,” they said in a statement.

The advocacy group said that additional funds for NIH and FDA will support innovative projects including precision medicine, Alzheimer’s research and efforts to combat antimicrobial resistance, however “the budget for the Agency for Healthcare Research and Quality was cut by eight percent in the spending bill, further limiting the agency’s ability to address costly errors and inefficiencies in health care delivery. Sustainable and predictable investments for AHRQ and other health agencies are critical to accelerating medical progress.”

The group also called attention to a bill being drafted by a Senate committee, called the Innovations for Healthier Americans Initiative, which is companion legislation for the 21st Century Cures bill, which passed in the House last year.

“Research!America urges Senate action early this year on legislation that responsibly modernizes regulatory pathways for new drugs and medical devices, and includes mandatory funding for the NIH and FDA. The goal must be to enact meaningful legislation this year.”

YOU MAY BE INTERESTED IN

The nagging pain in Mia Sandino’s right knee set in in September 2018, and throughout her freshman year at the University of Washington, she tried to ignore it. “I was being a very naive and invincible-feeling 19-year-old,” Sandino told The Cancer Letter. “I didn’t put two and two together that this area of the knee that...

Rick Pazdur, MD, the newly appointed director for the Center for Drug Evaluation and Research at the FDA, has been described as “greyhound thin” as a result of his dedication to cycling and lifting weights in the gym each day and, for a long time, a vegetarian diet. I first met him when he was the director of the Office of Oncology Drug Products (ODP) within CDER, in 2009.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login